Statistics

Total Visits

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study98

Select a period of time:

Number of views in the range

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study25

Views

Views
November 202514
December 20251
January 20261
February 20260
March 20261
April 20261
May 20267
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
United Kingdom3
Brazil3
Spain2
Argentina1
Colombia1
Honduras1
Iran1
South Korea1
Morocco1
 

Top cities views

Views
Los Angeles2
Amsterdam1
Bolingbrook1
Cereté1
Ciudad del Este1
Itapetininga1
Madrid1
Seoul1
Serra1
São João da Boa Vista1